5545809
Tocris Bioscience™ GSK 1838705
Potent IR and IGF1R inhibitor; also inhibits anaplastic lymphoma kinase (ALK)
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Purity
>98%
Product Type
GSK 1838705
Molecular Weight (g/mol)
532.57
Inhibitors
GSK 1838705
Related Products
Description
- Potent insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF1R) inhibitor (IC50 values are 1.6 and 2 nM, respectively)
- Also inhibits anaplastic lymphoma kinase (ALK) (IC50 = 0.5 nM)
- Displays > 800-fold selectivity for IR, IGFR1 and ALK over a panel of 44 kinases including JNK
- Blocks proliferation of cancer cell lines in vitro , and causes complete regression of ALK-dependent tumors in vivo
- Orally bioavailable.
Compare Similar Items
Show Difference
Purity: >98%
Product Type: GSK 1838705
Molecular Weight (g/mol): 532.57
Inhibitors: GSK 1838705
Purity:
>98%
Product Type:
GSK 1838705
Molecular Weight (g/mol):
532.57
Inhibitors:
GSK 1838705
Purity: >97%
Product Type: GSK 429286
Molecular Weight (g/mol): 432.37
Inhibitors: GSK 429286
Purity:
>97%
Product Type:
GSK 429286
Molecular Weight (g/mol):
432.37
Inhibitors:
GSK 429286
Purity: __
Product Type: GYY 4137 morpholine salt
Molecular Weight (g/mol): 376.47
Inhibitors: GYY 4137 morpholine salt
Purity:
__
Product Type:
GYY 4137 morpholine salt
Molecular Weight (g/mol):
376.47
Inhibitors:
GYY 4137 morpholine salt
Purity: __
Product Type: INCA-6
Molecular Weight (g/mol): 284.31
Inhibitors: INCA-6
Purity:
__
Product Type:
INCA-6
Molecular Weight (g/mol):
284.31
Inhibitors:
INCA-6